Argus analysts reiterated a Buy rating on Xilinx, Inc. (NASDAQ: XLNX) and raised the price target by $10.
Xilinx, a...
Traders got a small taste of the dangerous short squeeze potential that Fitbit Inc (NYSE: FIT) has this week when the...
Here is a look at some of the largest declining biotech names during the final week of 2016.
Anthera
Anthera...
Emerging markets debt exchange traded funds were supposed to be vulnerable in the face of the Federal Reserve's...
Shares of Opko Health Inc. (NASDAQ: OPK), a pharmaceutical and diagnostics company, plunged more than 15 percent on...
Thousands of digital items are now on sale on Amazon.com.
Amazon.com, Inc. (NASDAQ: AMZN) is hosting its first-ever...
Shares of Cabelas Inc (NYSE: CAB) plunged more than 5.5 percent on concerns that its merger with Bass Pro Shops would...
Hemispherx BioPharma, Inc (NYSE: HEB) is a nano-cap biopharmaceutical research and development company that focuses...
It's an open secret that Virtual Reality would be one of the central themes of 2017